Orapred Tablet, Orally Disintegrating
NDC Package 59212-702-48

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Orapred (prednisolone sodium phosphate) tablets is prednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. This formulation utilizes a tablet, orally disintegrating delivery system. Marketed by Advanz Pharma (us) Corp., this product is identified by NDC 59212-702 and is authorized under FDA application NDA021959.

Identification & Billing

NDC Package Code
59212-702-48
Package Description
8 BLISTER PACK in 1 CARTON / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (59212-702-06)
Product Code
59212-702
11-Digit Billing Format
59212070248
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
8 EA
RxNorm Crosswalk
  • RxCUI: 643123 - prednisoLONE sodium phosphate 10 MG Disintegrating Oral Tablet
  • RxCUI: 643123 - prednisolone 10 MG Disintegrating Oral Tablet
  • RxCUI: 643123 - prednisolone 10 MG (prednisolone sodium phosphate 13.4 MG) Disintegrating Oral Tablet
  • RxCUI: 643125 - prednisoLONE sodium phosphate 15 MG Disintegrating Oral Tablet
  • RxCUI: 643125 - prednisolone 15 MG Disintegrating Oral Tablet

Clinical Specifications

Proprietary Name
Orapred Odt
Non-Proprietary Name
Prednisolone Sodium Phosphate
Substance Name
Prednisolone Sodium Phosphate
Dosage Form
Tablet, Orally Disintegrating - A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
PREDNISOLONE SODIUM PHOSPHATE 30 mg/1
Pharmacologic Class
Usage Information
Prednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain and allergic-type reactions. This medication is a corticosteroid hormone. Prednisolone may also be used with other medications in hormone disorders.

Regulatory & Marketing

Labeler Name
Advanz Pharma (us) Corp.
Product Type
Human Prescription Drug
FDA Application #
NDA021959
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-01-2006
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (59212-702). Click a package code to view its specific billing and regulatory data.

59212-702-12
2 BLISTER PACK in 1 CARTON / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (59212-702-06)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59212-702-48 identifies a specific commercial package of 8 blister pack in 1 carton / 6 tablet, orally disintegrating in 1 blister pack (59212-702-06) of Orapred Odt, a human prescription drug labeled by Advanz Pharma (us) Corp.. This tablet, orally disintegrating is formulated for oral use and contains prednisolone sodium phosphate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Advanz Pharma (us) Corp. on June 01, 2006. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Prednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain and allergic-type reactions. This medication is a corticosteroid hormone. Prednisolone may also be used with other medications in hormone disorders.

How is this Advanz Pharma (us) Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59212070248. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 8 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59212-702-48
11-Digit CMS (5-4-2)
59212-0702-48

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.